Centre for Innate Immunity & Infectious diseases

Research at the Centre for Innate Immunity and Infectious Diseases has led to ground-breaking discoveries in innate immunology and the microbiome that are changing our understanding and treatment of cancer, inflammatory and infectious diseases.

Professor Richard Ferrero ARC Discovery Projects success

Acting Centre Head Professor Richard Ferrero

Overview

The Centre for Innate Immunity and Infectious Diseases (CiiiD) houses the largest group of inflammation and immunity researchers in Australia. They are world leaders in studying the body’s innate, or first-line, immune response and how it and the microbiome trigger inflammation, leading to cancer, autoimmune conditions (lupus, inflammatory bowel disease, arthritis), lung (COPD, emphysema, silicosis) and infectious diseases (gastroenteritis, influenza, pneumonia).

The Centre for Innate Immunity and Infectious Diseases goals are to

- Discover the steps and connections that turn inflammation on and off

- Develop new treatments for inflammatory diseases and cancer

- Identify markers that help diagnose and detect disease earlier.

Inflammation – the cause of disease

Scientists now know that uncontrolled destructive inflammation is the cause of more than 50 per cent of deaths worldwide and underpins hundreds of chronic diseases.

Inflammation is an essential immune response for survival. Although it protects against invaders (viruses, bacteria), it can also cause serious damage and even death. By finding the complex interconnections in inflammation, the Centre for Innate Immunity and Infectious Diseases scientists are finding new ways to treat common and serious illnesses from birth to old age.

In the past five years, the Centre’s scientists have published more than 300 peer-reviewed publications, including works in prestigious journals, such as Nature, Nature Biotechnology, Nature Communications, Nature Microbiology, PNAS USA, PLoS Pathogens, EMBO Molecular Medicine, Gastroenterol, Gut, and Journal of Clinical Investigation. Their fundamental discoveries have led to numerous national and international industry collaborations.

They were co-founders of the Victorian Infection and Immunity Network (VIIN) and the Australian TLR research network (TLROZ), and are involved in several national and international collaborations, such as the Australian Inflammation Cent

+ Read more

Diseases we research

Research groups

Group heads	Groups and research areas
Professor Philip Bardin	Respiratory and Lung COVID-19, Influenza
Professor Richard Ferrero	Gastrointestinal Infection and Inflammation Antimicrobial resistance, Gastroenteritis, Inflammation and cancer, Stomach cancer
Associate Professor Samuel Forster	Microbiota and Systems Biology Antimicrobial resistance, COVID-19, Gastroenteritis, Inflammatory bowel disease (IBD), Microbiome in health and disease
Associate Professor Michael Gantier	Nucleic Acids and Innate Immunity COVID-19, Inflammation and cancer, Influenza, Lupus
Professor Elizabeth Hartland	Innate Immune Responses to Infection Antimicrobial resistance, Gastroenteritis, Microbiome in health and disease, Pneumonia
Professor Paul Hertzog	Regulation of Interferon and Innate Signalling COVID-19, Inflammation and cancer, Inflammatory bowel disease (IBD), Influenza, Microbiome in health and disease, Lung cancer, Ovarian cancer, Endometriosis
Professor Brendan Jenkins	Cancer and Immune Signalling
Associate Professor Kate Lawlor	Cell Death and Inflammatory Signalling Inflammatory bowel disease (IBD), Influenza, Pneumonia
Associate Professor Ashley Mansell	Pattern Recognition Receptors and Inflammation COVID-19, Influenza, Pneumonia
Associate Professor Jaclyn Pearson	Host-Pathogen Interactions Antimicrobial resistance, Gastroenteritis, Inflammatory bowel disease (IBD)
Associate Professor Michelle Tate	Viral Immunity and Immunopathology COVID-19, Influenza, Pneumonia